- Home
- RAPT vs CSBR Comparison
RAPT vs CSBR Comparison
Compare RAPT & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- CSBR
- Stock Information
- Founded
- RAPT 2015
- CSBR 1985
- Country
- RAPT United States
- CSBR United States
- Employees
- RAPT N/A
- CSBR N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RAPT Health Care
- CSBR Health Care
- Exchange
- RAPT Nasdaq
- CSBR Nasdaq
- Market Cap
- RAPT 117.5M
- CSBR 113.0M
- IPO Year
- RAPT 2019
- CSBR 1986
- Fundamental
- Price
- RAPT $0.75
- CSBR $6.21
- Analyst Decision
- RAPT Hold
- CSBR Strong Buy
- Analyst Count
- RAPT 7
- CSBR 1
- Target Price
- RAPT $5.00
- CSBR $12.00
- AVG Volume (30 Days)
- RAPT 829.4K
- CSBR 42.0K
- Earning Date
- RAPT 05-08-2025
- CSBR 03-11-2025
- Dividend Yield
- RAPT N/A
- CSBR N/A
- EPS Growth
- RAPT N/A
- CSBR N/A
- EPS
- RAPT N/A
- CSBR 0.46
- Revenue
- RAPT N/A
- CSBR $58,591,000.00
- Revenue This Year
- RAPT N/A
- CSBR $15.11
- Revenue Next Year
- RAPT N/A
- CSBR $7.80
- P/E Ratio
- RAPT N/A
- CSBR $12.94
- Revenue Growth
- RAPT N/A
- CSBR 19.03
- 52 Week Low
- RAPT $0.75
- CSBR $3.60
- 52 Week High
- RAPT $8.58
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- RAPT 33.73
- CSBR 36.72
- Support Level
- RAPT $0.75
- CSBR $5.65
- Resistance Level
- RAPT $0.85
- CSBR $8.27
- Average True Range (ATR)
- RAPT 0.08
- CSBR 0.57
- MACD
- RAPT -0.00
- CSBR -0.08
- Stochastic Oscillator
- RAPT 0.97
- CSBR 21.67
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.